EUROTOX 2019 - 55th Congress of the European Societies of Toxicology

Date: 
Sunday, 8 September, 2019 (All day) to Wednesday, 11 September, 2019 (All day)
Topic: 

The EUROTOX2019 Scientific Programme Committee, chaired by Prof. H. Wallace, has prepared an exciting scientific programme, highlighting the latest research results and trends in the field of toxicology.

SESSIONS

  • Challenges of non-animal approaches for food safety: from inception to application
  • Knowledge-based computational approaches in predictive toxicology
  • Application of NAMs and development of IATAs-moving toward mechanistic risk assessment
  • Understanding the interindividual variability in toxicity involving the psychotropic drugs
  • Investigative Toxicology Leaders Forum (ITLF): Scientific advancements and case studies for the optimization of drug discovery. Trends in investigative toxicology
  • The process of ageing and its modulation: telomeres as biomarkers in in vitro and in vivo studies
  • Speeding up hazard assessment of nanomaterials
  • Fetus – the most sensitive individual
  • Experimental comprehensive toxicological studies simulating real-life exposures: long-term combined exposures on multi endpoints
  • Biomarkers in predictive toxicology and risk assessment
  • Endocrine Disruption: identification of root causes
  • Comprehensive toxicological profiles in nanoformulations for blood brain barrier
  • Advancing toxicological evaluations in resolving current policy controversies in GMO products
  • Neurotoxicity in the scientific and regulatory outlook
  • Toxic epidemics: why should we still be worried in 2019?
  • The Exposome – Understanding the role of environmental exposure in human health and disease
  • Detection, assessment, management and communication of risk in mass human toxic exposures
  • Metabolic capacity and functionality of the gut microbiome
  • Implications of biodistribution of inhaled nanoparticles: effects in organs other than the lung
  • Human adaptation to environmental pollution: dose-response relationship revisited
  • Developments in the use of systematic review in chemical risk assessment
  • Chemical risk assessment using human in vitro, ex vivo, in silico and biomonitoring data
  • New tools and application in reg. risk assessment – moving toward mechanistic risk assessment
  • Hepatotoxicity-mechanisms, new insight into liver function, and possibilities of in vitro prediction
  • Suitability of non-animal approaches in different industries: One size fits all?
  • How innate immune cells recognize toxicants – consequences for immune-mediated toxicity
  • Optimization of existing and construction of new testing strategies for skin sensitization potency
  • Investigative Toxicology Leaders Forum (ITLF): Scientific advancements and case studies for the optimization of drug discovery. DILI case studies
Place: 
Helsinki, Finland